Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can an 8-Week online mindfulness course ease fibromyalgia pain?

NCT ID NCT07410572

Symptom relief Sponsor: Gazi University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested an 8-week online mindfulness-based stress reduction program in 94 adults with fibromyalgia. Participants were randomly assigned to the online program or usual care. The goal was to see if the program could reduce pain catastrophizing and improve daily function.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
online mindfulness-based stress reduction program
What this could lead to
If it works, this could offer an accessible, drug-free way to help manage fibromyalgia symptoms like pain and fatigue.
What could go wrong
This is a small, completed trial with 94 participants. Results may not apply to everyone, and online delivery might not suit all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

94 people

The number who actually took part.

Started

Jan 2024

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 to 65 years * Willingness to participate in the study and provision of written informed consent * Completion of at least 8 years of compulsory education * Montreal Cognitive Assessment (MoCA) score ≥ 21 * Diagnosis of fibromyalgia syndrome according to the 2016 American College of Rheumatology (ACR) criteria * Pain severity of ≥ 4 cm on the Visual Analog Scale (VAS) during the previous 7 days Exclusion Criteria: * Age below 18 years or above 65 years * Refusal to participate in the study * Completion of less than 8 years of compulsory education * MoCA score \< 21 * Absence of fibromyalgia diagnosis according to the 2016 ACR criteria * Pain severity of \< 4 cm on the Visual Analog Scale (VAS) during the previous 7 days * History of migraine or any peripheral or central neurological disorder * History of inflammatory rheumatic diseases * History of malignancy * Pregnancy or lactation * Presence of conditions associated with significant cognitive impairment (e.g., dementia, amnestic disorders, intellectual disability) * Presence of bipolar disorder, psychotic disorders, severe depressive disorder, alcohol or substance use disorder, or active suicidal ideation * Previous participation in any mindfulness-based intervention or training program

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fibromyalgia syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

fibromyalgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fibromyalgia syndrome

Contacts and locations

Locations

  • Gazi University Hospital

    Ankara, Ankara, 06500, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.